NASDAQ:CVET - Nasdaq - US22304C1009 - Common Stock - Currency: USD
20.99
+0.06 (+0.29%)
The current stock price of CVET is 20.99 USD. In the past month the price increased by 0.53%. In the past year, price increased by 5.58%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
MCK | MCKESSON CORP | 20.5 | 74.91B | ||
COR | CENCORA INC | 16.99 | 46.77B | ||
CAH | CARDINAL HEALTH INC | 16.44 | 30.69B | ||
HSIC | HENRY SCHEIN INC | 18.35 | 9.59B | ||
PDCO | PATTERSON COS INC | 14.66 | 2.74B | ||
AHCO | ADAPTHEALTH CORP | N/A | 1.14B | ||
AHG | AKSO HEALTH GROUP | N/A | 518.47M | ||
OMI | OWENS & MINOR INC | 3.75 | 479.62M | ||
COSM | COSMOS HEALTH INC | N/A | 14.34M | ||
VRAX | VIRAX BIOLABS GROUP LTD | N/A | 8.12M | ||
ATPC | AGAPE ATP CORP | N/A | 3.73M |
Covetrus, Inc. is an animal-health technology and services company, which serves animal veterinary markets. The Company operates through three segments. North America segment offers supply chain services, software services and prescription management to its customers and animal-owners. Europe segment offers supply chain services and software services to its customers and animal-owners. Asia-Pacific & Emerging Markets segment offers supply chain services and software services to its customers and animal-owners. The Company's products and services include supply chain services, software services, and prescription management. It offers a comprehensive portfolio of products, services and value-added solutions for enhancing delivering animal care. It develops, provides and supports veterinary practices with a range of veterinary software systems. These technology solutions include practice management software, data-driven applications, client communications tools, and related services.
Covetrus Inc
7 Custom House St
Portland MAINE 04101 US
CEO: Benjamin Wolin
Employees: 4035
Company Website: https://covetrus.com/
Phone: 18882802221.0
The current stock price of CVET is 20.99 USD. The price increased by 0.29% in the last trading session.
The exchange symbol of Covetrus Inc is CVET and it is listed on the Nasdaq exchange.
CVET stock is listed on the Nasdaq exchange.
11 analysts have analysed CVET and the average price target is 21.76 USD. This implies a price increase of 3.67% is expected in the next year compared to the current price of 20.99. Check the Covetrus Inc stock analysts ratings, price target forecast and up-and down grades for more detailed information.
Covetrus Inc (CVET) has a market capitalization of 2.94B USD. This makes CVET a Mid Cap stock.
Covetrus Inc (CVET) currently has 4035 employees.
Covetrus Inc (CVET) has a support level at 20.91 and a resistance level at 21. Check the full technical report for a detailed analysis of CVET support and resistance levels.
The Revenue of Covetrus Inc (CVET) is expected to grow by 4.28% in the next year. Check the estimates tab for more information on the CVET EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
CVET does not pay a dividend.
Covetrus Inc (CVET) will report earnings on 2022-11-03, after the market close.
The PE ratio for Covetrus Inc (CVET) is 21.2. This is based on the reported non-GAAP earnings per share of 0.99 and the current share price of 20.99 USD. Check the full fundamental report for a full analysis of the valuation metrics for CVET.
ChartMill assigns a technical rating of 7 / 10 to CVET. When comparing the yearly performance of all stocks, CVET is one of the better performing stocks in the market, outperforming 88.09% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to CVET. The financial health of CVET is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months CVET reported a non-GAAP Earnings per Share(EPS) of 0.99. The EPS increased by 4.89% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | -0.28% | ||
ROA | -0.38% | ||
ROE | N/A | ||
Debt/Equity | 0.65 |
ChartMill assigns a Buy % Consensus number of 51% to CVET. The Buy consensus is the average rating of analysts ratings from 11 analysts.
For the next year, analysts expect an EPS growth of 16.83% and a revenue growth 4.28% for CVET